Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on September 7, 2006
J Am Soc Nephrol 17: 2892-2899, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2005101122

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005101122v1
17/10/2892    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peralta, C. A.
Right arrow Articles by Go, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peralta, C. A.
Right arrow Articles by Go, A. S.

Epidemiology and Outcomes

Risks for End-Stage Renal Disease, Cardiovascular Events, and Death in Hispanic versus Non-Hispanic White Adults with Chronic Kidney Disease

Carmen A. Peralta*,{dagger}, Michael G. Shlipak*,{dagger},{ddagger}, Dongjie Fan§, Juan Ordoñez||, James P. Lash, Glenn M. Chertow{dagger},{ddagger} and Alan S. Go{dagger},{ddagger},§

* General Internal Medicine Section, San Francisco Veterans Affairs Medical Center, Departments of {dagger} Medicine and {ddagger} Epidemiology and Biostatistics, University of California, San Francisco, and § Division of Research, Kaiser Permanente of Northern California, || Division of Nephrology, Kaiser Permanente Oakland Medical Center, Oakland, California; and Division of Nephrology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois

Address correspondence to: Dr. Alan S. Go, Division of Research, Kaiser Permanente of Northern California, 2000 Broadway Street, 3rd Floor, Oakland, CA 94612-2304. Phone: 510-891-3553; Fax: 510-891-3606; E-mail: alan.s.go{at}kp.org

Received for publication October 26, 2005. Accepted for publication July 25, 2006.

Rates of ESRD are rising faster in Hispanic than non-Hispanic white individuals, but reasons for this are unclear. Whether rates of cardiovascular events and mortality differ among Hispanic and non-Hispanic white patients with chronic kidney disease (CKD) also is not well understood. Therefore, this study examined the associations between Hispanic ethnicity and risks for ESRD, cardiovascular events, and death in patients with CKD. A total of 39,550 patients with stages 3 to 4 CKD from Kaiser Permanente of Northern California were included. Hispanic ethnicity was obtained from self-report supplemented by surname matching. GFR was estimated from the abbreviated Modification of Diet in Renal Disease equation, and clinical outcomes, patient characteristics, and longitudinal medication use were ascertained from health plan databases and state mortality files. After adjustment for sociodemographic characteristics, Hispanic ethnicity was associated with an increased risk for ESRD (hazard ratio [HR] 1.93; 95% confidence interval [CI] 1.72 to 2.17) when compared with non-Hispanic white patients, which was attenuated after controlling for diabetes and insulin use (HR 1.50; 95% CI 1.33 to 1.69). After further adjustment for potential confounders, Hispanic ethnicity remained independently associated with an increased risk for ESRD (HR 1.33; 95% CI 1.17 to 1.52) as well as a lower risk for cardiovascular events (HR 0.82; 95% CI 0.76 to 0.88) and death (HR 0.72; 95% CI 0.66 to 0.79). Among a large cohort of patients with CKD, Hispanic ethnicity was associated with lower rates of death and cardiovascular events and a higher rate of progression to ESRD. The higher prevalence of diabetes among Hispanic patients only partially explained the increased risk for ESRD. Further studies are required to elucidate the cause(s) of ethnic disparities in CKD-associated outcomes.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. I. Yilmaz, M. Saglam, J. J. Carrero, A. R. Qureshi, K. Caglar, T. Eyileten, A. Sonmez, E. Cakir, M. Yenicesu, B. Lindholm, et al.
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
Nephrol. Dial. Transplant., March 1, 2008; 23(3): 959 - 965.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. Ferris, S. L. Hogan, H. Chin, D. A. Shoham, D. S. Gipson, K. Gibson, S. Yilmaz, R. J. Falk, and J. C. Jennette
Obesity, Albuminuria, and Urinalysis Findings in US Young Adults from the Add Health Wave III Study
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1207 - 1214.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP